AI Summary
Description
VHAPG Part 806.3 OFOC Page 1 of 4 Revision: 04 Effective Date: 12/15/25 Acquisition ID#: 36C249-26-AP-1835 DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) IAW FAR Overhaul Part 12.102(b) Acquisition Plan Action ID: 36C249-26-AP-1835 Contracting Activity: Department of Veterans Affairs, Network Contracting Office 9 on behalf of VISN 9, James H. Quillen VA Medical Center Purchase Request: 621-26-3-037-0534 Nature and/or Description of the Action Being Approved: Sole source 24 month Blanket Purchase Agreement with Firm Fixed Unit Price Cost consumables with an estimated value of $880,000 and a period of performance from 6/1/2026 to 5/30/2028. Description of Supplies/Services Required to Meet the Agency s Needs: This acquisition is for the rental of two Roche-VENTANA BenchMark ULTRA PLUS (FS) Immunohistochemical Stainers (IHC Stainers) and one Benchmark Special Stainer for the Histology section of the Pathology and Laboratory Medicine Service (PLMS) at the James H. Quillen VA Medical Center (VAMC) at 809 Lamont Street, Mountain Home, TN 37684. The acquisition includes all reagents, related stains, antibodies, consumables, technical support, associated services, and includes quarterly decontamination services. The required items and services are necessary to produce quality stained slides, which are evaluated by pathologists and assist in the diagnosis of patients. Statutory Authority Permitting Other than Full and Open Competition in accordance with FAR Overhaul Part 12.102(b): Only One Responsible Source and No Other Supplies or Services Will Satisfy Agency Requirements per 41 U.S.C. 1901. Demonstration that the Contractor s Unique Qualifications or Nature of the Acquisition Requires the Use of the Authority Cited Above (applicability of authority): James H. Quillen VAMC uses the Roche Ventana Benchmark Ultra IHC Stainer and the Roche Ventana Ultra Benchmark Special Stainer. The Roche IHC and Special Stainer platforms offer the ability to add/remove slides without stopping workflow. These Stainers provide an exact footprint on restrictive available space. Roche reagents provide a unique capability to be added or removed from the Roche system without impacting workflow with the use of individual drawers. The system capability eliminates batch runs which provides operators continuous access to the system, thus preventing delays in patient tissue staining and subsequent diagnosis. The Special Stainer capability eliminates accidental use of expired reagents and mislabeling of reagents with manual entry. The Roche staining platform is the only staining system that meets the requirement in its entirety. Description of Efforts Made to ensure that offers are solicited from as many potential sources as possible (including whether a notice was or will be publicized as required by RFO Part 5 and, if not, which exception under RFO Part 5 applies): This justification will be posted in accordance wit…
Award Details
Classification
Contracting Office
Contacts
Attachments (1)